An orally available non-nucleotide STING agonist with antitumor activity

Pan, Bo-Sheng, Perera, Samanthi A., Piesvaux, Jennifer A., Presland, Jeremy P., Schroeder, Gottfried K., Cumming, Jared N., Trotter, B. Wesley, Altman, Michael D. +33 more·2020·Science

Cited by (709)

Items 201–300 of 709

  1. Pharmacological Targeting of STING-Dependent IL-6 Production in Cancer Cells
    Sumaiah S. Al-Asmari, Aleksandra Rajapakse, Tomalika Rahmat Ullah, Geneviève Pépin, Laura V. Croft, Michael Paul Gantier · 2022 · Frontiers in Cell and Developmental Biology
  2. Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells
    Ruben Serrano, Marcus Lettau, Michał Konrad Zarobkiewicz, Daniela Wesch, Christian Peters, Dieter Kabelitz · 2022 · OncoImmunology
  3. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy
    Reschke, Robin, Olson, Daniel · 2022 · Cancers
  4. Targeting neutrophils potentiates hitchhiking delivery of drugs and agonists for postsurgical chemo-immunotherapy
    Zhiliang Gao, Ning Wang, Yuan Ma, Hongning Sun, Mengqi Li, Yunlu Dai, Xinyi Jiang, Shilei Ni, Jingcheng Hao, Jiwei Cui · 2023 · Nano Today
  5. AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation
    Dan‐Ling Dai, Chu Xie, Lan‐Yi Zhong, Shangxin Liu, Lele Zhang, Hua Zhang, Xingping Wu, Zhou-Ming Wu, Kexin Kang, Yan Li et al. · 2024 · Signal Transduction and Targeted Therapy
  6. Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy-induced antitumor immunity
    Zimeng Yang, Hengzhi Liu, Shuo Li, Zhaochu Xu, Wenxiao Li, Yubo Liu, Qingzhi Lv, Hongzhuo Liu, Zhonggui He, Yongjun Wang · 2025 · Science Advances
  7. Chemical regulation of the cGAS-STING pathway
    Qian Zhang, Chen Chen, Bing Xia, Pinglong Xu · 2022 · Current Opinion in Chemical Biology
  8. Novel formulation of c-di-GMP with cytidinyl/cationic lipid reverses T cell exhaustion and activates stronger anti-tumor immunity
    Xiaotong Yu, Jing Yu, Hong Dai, Chenyun Deng, Xudong Sun, Sijie Long, Zhujun Jiang, Hongyan Jin, Zhu Guan, Zhenjun Yang · 2022 · Theranostics
  9. At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment
    Tatyana V. Korneenko, Nikolay Borisovich Pestov, Ivan A. Nevzorov, Alexandra A. Daks, Трачук Кирилл Николаевич, О. Н. Солопова, Nickolai A. Barlev · 2023 · Pharmaceuticals
  10. Spatiotemporal release of non-nucleotide STING agonist and AKT inhibitor from implantable 3D-printed scaffold for amplified cancer immunotherapy
    Haixia Wang, Zheng Liu, Youqiang Fang, Xing Luo, Chunxiong Zheng, Yanteng Xu, Xiangfu Zhou, Qing Yuan, Shixian Lv, Limin Ma et al. · 2024 · Biomaterials
  11. Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
    Wei Liu, Mohamad‐Gabriel Alameh, June F. Yang, Jonathan R. Xu, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Jianxin You · 2022 · International Journal of Molecular Sciences
  12. Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone
    Ruilei Huang, Qian Ning, Jihui Zhao, Xuhong Zhao, Luting Zeng, Yi Yi, Shengsong Tang · 2023 · Biochemical Pharmacology
  13. A DNA‐Modularized STING Agonist with Macrophage‐Selectivity and Programmability for Enhanced Anti‐Tumor Immunotherapy
    Yingzhi Chen, Ruike Li, Qiao Duan, Lingling Wu, Xinyi Li, Aoxiang Luo, Yongming Zhang, Na Zhao, Kai Cui, Wenwei Wu et al. · 2024 · Advanced Science
  14. Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation
    Li Liu, Shengxiang Fu, Haojie Gu, Yangqian Li, Guonian Zhu, Hua Ai, Weimin Li · 2025 · ACS Nano
  15. The cGAS‒STING pathway in colorectal cancer: bridging innate immunity and therapeutic strategies
    Wenjing Li, Guang-Hui Dong, Yao Bi, You-Yan Han, Longlong Sun, Tong Wang, Zhenhua Lin, Xiang-Shan Ren · 2025 · Journal of Experimental & Clinical Cancer Research
  16. Cytosolic sensor STING in mucosal immunity: a master regulator of gut inflammation and carcinogenesis
    Qiongyuan Hu, Quan Zhou, Xuefeng Xia, Lihua Shao, Meng Wang, Xiaofeng Lu, Song Liu, Wenxian Guan · 2021 · Journal of Experimental & Clinical Cancer Research
  17. The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges
    Zheqi Zhou, Sanling Huang, Fangying Fan, Yan Xu, Casey Moore, Sirui Li, Chuanhui Han · 2024 · Medical Review
  18. cGAS-STING: mechanisms and therapeutic opportunities
    Mengyuan Zhang, Changxin Wu, Defen Lu, Xing Wang, Guijun Shang · 2025 · Science China Life Sciences
  19. Discovery of Potent STING Inhibitors Bearing a Difluorobenzodioxol Structural Motif as Potent Anti-Inflammatory Agents
    Ancheng Shen, Xiyuan Wang, Qingxuan Chen, Yan Zhang, Fang Wang, Yuqiang Li, Zhiguo Liu, Liufu Deng, Wanli Ouyang, Meiyu Geng et al. · 2025 · Journal of Medicinal Chemistry
  20. Unveiling the crossroads of STING signaling pathway and metabolic reprogramming: the multifaceted role of the STING in the TME and new prospects in cancer therapies
    Siwei Wang, Lu Qin, Furong Liu, Zhanguo Zhang · 2025 · Cell Communication and Signaling
  21. Methotrexate exerts antitumor immune activity and improves the clinical efficacy of immunotherapy in patients with solid tumors
    Ruirui Yang, Wang Bei, Zhaoming Su, Ying Song, Yingying Zhang, Yadan Liu, Yinghui Zhang, Changyu He, Yang Xi, Feisheng Zhong et al. · 2025 · Science Translational Medicine
  22. Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act
    Xujun Cao, Anthony F. Cordova, Lingyin Li · 2021 · Chemical Reviews
  23. A hierarchical tumor-targeting strategy for eliciting potent antitumor immunity against triple negative breast cancer
    Minzhao Lin, Yujun Cai, Gengjia Chen, Huihai Zhong, Bo Li, Li Tan, Zecong Xiao, Xintao Shuai · 2023 · Biomaterials
  24. Protein–Ligand Interactions in the STING Binding Site Probed by Rationally Designed Single-Point Mutations: Experiment and Theory
    Zdeněk Vavřina, Ondrej Gutten, Miroslav Smola, Martin Zavřel, Zahra Aliakbar Tehrani, Vilém Charvát, Milan Kožíšek, Evžen Bouřa, Gabriel Birkuš, Lubomı́r Rulı́šek · 2021 · Biochemistry
  25. Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway
    Jiaorong Qu, Yajie Cai, Fanghong Li, Xiaojiaoyang Li, Runping Liu · 2024 · EBioMedicine
  26. Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
    Mi Young Lim, Seungpyo Hong, Young‐Do Nam · 2025 · Frontiers in Immunology
  27. Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy
    Peng Xia, Chengming Qu, Xiaolong Xu, Ming Tian, Zhifen Li, Jingbo Ma, Rui Hou, Han Li, Felix Rückert, Tianyu Zhong et al. · 2025 · Journal of Extracellular Vesicles
  28. Bacterial Cyclic Dinucleotides and the cGAS–cGAMP–STING Pathway: A Role in Periodontitis?
    Samira Elmanfi, Mustafa Yılmaz, Wilson W. S. Ong, Kofi Simpa Yeboah, Herman O. Sintim, Mervi Gürsoy, Eija Könönen, Ulvi Kahraman Gürsoy · 2021 · Pathogens
  29. Design of a systemic small molecule clinical STING agonist using physics-based simulations and artificial intelligence
    Bryce K. Allen, Meghana M. Kulkarni, Brian T. Chamberlain, Timothy Dwight, Cheryl M. Koh, Ramya Samant, Finith E. Jernigan, Jamie Rice, Dazhi Tan, Stella Li et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Mesoporous Microneedles Enabled Localized Controllable Delivery of Stimulator of Interferon Gene Agonist Nanoexosomes for FLASH Radioimmunotherapy against Breast Cancer
    Zhiran Chen, Fangjie Hu, Jingfeng Xiang, Xiaoxiang Zhou, Bo Wu, Baohang Fan, Han Tang, Bin Liu, Longyun Chen · 2024 · ACS Applied Materials & Interfaces
  31. Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review)
    Annette Affolter, Johann Kern, Karen Bieback, Claudia Scherl, Nicole Rotter, Anne Lammert · 2022 · International Journal of Oncology
  32. A prodrug nanoplatform via esterification of STING agonist and IDO inhibitor for synergistic cancer immunotherapy
    Madiha Zahra Syeda, Tu Hong, Min Zhang, Yanfei Han, Xiaoling Zhu, Songmin Ying, Longguang Tang · 2022 · Nano Research
  33. Structure−Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists
    Ancheng Shen, Xiyuan Li, Yan Zhang, Jing Ma, Ruoxuan Xiao, Xiyuan Wang, Zilan Song, Zhiguo Liu, Meiyu Geng, Ao Zhang et al. · 2022 · European Journal of Medicinal Chemistry
  34. Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity
    Kim, Jennie C., Liu, Xian, Fitzgerald, Karen, Eng, Jason S., Orf, Jessica, O’Brien, Sarah A., Belmontes, Brian, Casbon, Amy-Jo, Novitskiy, Sergey V., Tarbell, Kristin V. et al. · 2023 · Cancer Immunology, Immunotherapy
  35. Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury
    Duo Xu, Fan Yang, Jiayao Chen, Tianxing Zhu, Fen Wang, Yitai Xiao, Zibin Liang, Lei Bi, Guolong Huang, Zebo Jiang et al. · 2022 · Acta Pharmaceutica Sinica B
  36. Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
    Jiajia Chang, Shi Xiang Hou, Xinlin Yan, Wei Li, Junhai Xiao · 2023 · Molecules
  37. Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth
    Chunyong Ding, Mengyan Du, Zhi Xiong, Xue Wang, Hongji Li, Ende He, Li Han, Yijing Dang, Qing Lü, Shicong Li et al. · 2023 · Chemical Science
  38. Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity
    Yoshimasa Suzuki, TAKESHI A. SATO, Makoto Sugimori, Yushi Kanemaru, Sho Onodera, Hiromi Tsuchiya, Yoshinori Nakamori, Sho Tsuyuki, Aya Ikeda, Ryosuke Ikeda et al. · 2024 · Scientific Reports
  39. Small-molecule in cancer immunotherapy: Revolutionizing cancer treatment with transformative, game-changing breakthroughs
    Soumyadeep Chattopadhyay, Rudradeep Hazra, Arijit Mallick, Sakuntala Gayen, Souvik Roy · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  40. Targeting STING signaling for the optimal cancer immunotherapy
    Yan Xu, Ying Xiong · 2024 · Frontiers in Immunology
  41. The common HAQ STING allele prevents clinical penetrance of COPA syndrome
    Noa Simchoni, Shogo Koide, Maryel Likhite, Yoshihiko Kuchitsu, Senkottuvelan Kadirvel, Christopher S. Law, Brett M. Elicker, Santosh Kurra, Margaret Mei-Kay Wong, Bo Yuan et al. · 2024 · The Journal of Experimental Medicine
  42. Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
    Shanshan Chen, Anghui Peng, Muhe Chen, Meixiao Zhan · 2023 · Frontiers in Oncology
  43. Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity
    Yingqi Liu, Fei Yang, Xuan Wang, Bingbing Yang, Menghuan Li, Zhong Yuan Luo · 2023 · Molecular Therapy
  44. Recent trends in STING modulators: Structures, mechanisms, and therapeutic potential
    Yan Zou, Min Zhang, Jinming Zhou · 2023 · Drug Discovery Today
  45. The battle between the innate immune cGAS-STING signaling pathway and human herpesvirus infection
    Ximing Jin, Wenjia Wang, Xinwei Zhao, Wenhua Jiang, Qingqing Shao, Zhuo Chen, Cong Mei Huang · 2023 · Frontiers in Immunology
  46. CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade
    Tomoko Morita, Jie Yu, Yukie Kashima, Ryo Kamata, Gaku Yamamoto, Tatsunori Minamide, Chiaki Mashima, Miyuki Yoshiya, Yuta Sakae, Toyohiro Yamauchi et al. · 2023 · Nature Communications
  47. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems
    Quentin T. L. Pasquer, Ioannis A. Tsakoumagkos, Sascha Hoogendoorn · 2020 · Molecules
  48. Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy
    Giulia Mazzaschi, Alessandro Leonetti, Roberta Minari, Letizia Gnetti, Federico Quaini, Marcello Tiseo, Francesco Facchinetti · 2021 · Current Treatment Options in Oncology
  49. Bioactive metallic nanoparticles for synergistic cancer immunotherapy
    Lulu Wang, Demin Lin, Mu‐Qing Li, Jiang Yu, Yanfang Yang, Hongliang Wang, Hongqian Chu, Jun Ye, Yuling Liu · 2025 · Acta Pharmaceutica Sinica B
  50. Conjugated STING agonists
    Shuhao Qu, Hong Dai · 2025 · Molecular Therapy — Nucleic Acids
  51. A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice
    Jianyang Fang, Lixia Feng, Lingxin Meng, Xiaobo Wang, Huanhuan Liu, Lumei Huang, Deliang Zhang, Jingchao Li, Rongqiang Zhuang, Zhide Guo et al. · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
  52. Small-Molecule Drugs in Immunotherapy
    Qing Su, Xuanrun Hao, Zhongliang Chen, Haining Li, Minqin Wei, Zhili Zuo · 2022 · Mini-Reviews in Medicinal Chemistry
  53. Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity
    Haipeng Liu, Hang Su, Fei Wang, Yifang Dang, Yijiu Ren, Shenyi Yin, Huinan Lu, Hang Zhang, Jun Wu, Zhu Xu et al. · 2023 · Cell Reports
  54. STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [ 18 F]FLT PET imaging
    Keke Liang, Evan R. Abt, Thuc M. Le, Arthur Eung-Hyuck Cho, Amanda M. Dann, Jing Cui, Luyi Li, Khalid Rashid, Amanda L. Creech, Wei Liu et al. · 2021 · Proceedings of the National Academy of Sciences
  55. Discovery of Pyrido[2,3-d]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment
    Yaoliang Sun, Manman Chen, Yuyan Han, Weiqiang Li, Xiaoyu Ma, Zihan Shi, Yang Zhou, Lan Xu, Lei Yu, Yuxiang Wang et al. · 2024 · Journal of Medicinal Chemistry
  56. Unleashing the Potential of Metal Ions in cGAS-STING Activation: Advancing Nanomaterial-Based Tumor Immunotherapy
    Xingyin Li, Shaojie Xu, Ziliang Su, Zengwu Shao, Xin Huang · 2025 · ACS Omega
  57. A stimuli-responsive cuproptosis switch boosts persistent immunotherapy for tumor eradication
    Jinming Cai, Sheng Shi, Jinyan Hu, Zhenlin Zhang, Bijiang Geng, Dengyu Pan, Longxiang Shen · 2025 · Biomaterials
  58. STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence
    Qi Shang, Chenwei Jiang, Mingmei Guo, Minglu Tang, Jiapei Yang, Junjie Xie, Xiaoran An, Qiang Zhang, Feihu Wang · 2026 · Science Advances
  59. Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential
    Milan Dejmek, Michal Šála, Andrea Brázdová, Lenka Vaneková, Miroslav Smola, Martin Klíma, Petra Břehová, Miloš Buděšı́nský, Martin Dračínský, Eliška Procházková et al. · 2022 · Structure
  60. Exogenous DNA enhances DUOX2 expression and function in human pancreatic cancer cells by activating the cGAS-STING signaling pathway
    Stephen L. Wang, Yongzhong Wu, Mariam M. Konaté, Jiamo Lu, David J. Mallick, Smitha Antony, Jennifer L. Meitzler, Guojian Jiang, Iris M. Dahan, Agnes N. Juhasz et al. · 2023 · Free Radical Biology and Medicine
  61. Targeting the stimulator of interferon genes (STING) in breast cancer
    MA Ying-rui, Bai Bu-Fan, Liu Deng, Shi Rong, Qianmei Zhou · 2023 · Frontiers in Pharmacology
  62. GAS-STING: a classical DNA recognition pathways to tumor therapy
    Xinrui Wang, Meijia Lin, Liping Zhu, Zhoujie Ye · 2023 · Frontiers in Immunology
  63. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression
    Xiaoyu Ma, Man-man Chen, Linghua Meng · 2024 · Acta Pharmacologica Sinica
  64. Self-assembly of a ruthenium-based cGAS-STING photoactivator for carrier-free cancer immunotherapy
    Yu‐Yi Ling, Zhi-Yuan Li, Xia Mu, Ya-Jie Kong, Hao Liang, Wen‐Jin Wang, Qing‐Hua Shen, Yue-Bin Zhang, Cai‐Ping Tan · 2024 · European Journal of Medicinal Chemistry
  65. Navigating the Complexity of Resistance in Lung Cancer Therapy: Mechanisms, Organoid Models, and Strategies for Overcoming Treatment Failure
    Da Hyun Kang, Jisoo Lee, Subin Im, Chaeuk Chung · 2024 · Cancers
  66. A tumor-targeting porphyrin-micelle with enhanced STING agonist delivery and synergistic photo-/immuno- therapy for cancer treatment
    Yuqing Pan, Haijing Qu, Han Chen, Wei Cheng, Zhiran Duan, Jiaojiao Yang, Ning Wang, Jie Wu, Yanjun Wang, Chao Wang et al. · 2024 · Acta Biomaterialia
  67. Chemical evolution of cyclic dinucleotides: Perspective of the analogs and their preparation
    Zhenghua Wang, Zhen Xi · 2021 · Tetrahedron
  68. Polyvalent design in the cGAS-STING pathway
    Zachary T. Bennett, Suxin Li, Baran D. Sumer, Jinming Gao · 2021 · Seminars in Immunology
  69. Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy
    Yi Qiao, Lingyu Wei, Yinjie Su, Qinyuan Tan, Xuecheng Yang, Shengxian Li · 2025 · International Journal of Nanomedicine
  70. Manganese in health and disease
    Yingchen Wang, Jinyou Li, Zhuang Jing, Yinhang Wu, Jiang Liu, Shuwen Han · 2025 · Nutrition Research Reviews
  71. Biomaterials nanoplatform-based tumor vaccines for immunotherapy
    Zhilin Li, Hongbin Zhang, Qiyong Gong, Kui Luo · 2025 · Bioactive Materials
  72. Metal-organic frameworks activate the cGAS-STING pathway for cancer immunotherapy
    Shuxuan Zhu, Wenfei Xu, Hongxia Li, Zhaogang Sun, Ying‐Jie Zhu, Wenjing Liu, Hongqian Chu · 2025 · Journal of Nanobiotechnology
  73. Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy
    Wen Su, Mixiao Tan, Zhihang Wang, Jie Zhang, Wenping Huang, Haohao Song, Xinye Wang, Haitao Ran, Yanfeng Gao, Guangjun Nie et al. · 2023 · Angewandte Chemie
  74. Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist
    Ruochen Zang, Liang Xue, Meifang Zhang, Xiaoyue Peng, Xionghao Li, Kaixin Du, Chuanqin Shi, Yuqian Liu, Yuxi Lin, Wenwei Han et al. · 2023 · European Journal of Medicinal Chemistry
  75. Fine-tuning Bacterial Cyclic di-AMP Production for Durable Antitumor Effects Through the Activation of the STING Pathway
    Yu Jiang, Xiyuan Li, Fenghui Qian, Bingbing Sun, Xiyuan Wang, Yan Zhang, Deqiang Zhang, Meiyu Geng, Zuoquan Xie, Sheng Yang · 2023 · Research
  76. Data-driven discovery of innate immunomodulators via machine learning-guided high throughput screening
    Yifeng Tang, Jeremiah Y. Kim, Carman KM IP, Azadeh Bahmani, Qing Chen, Matthew Glenn Rosenberger, Aaron Palmer Esser-Kahn, Andrew L. Ferguson · 2023 · Chemical Science
  77. In situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response
    Teenesha Chellen, Mathilde Bausart, Pierre Maus, Kévin Vanvarenberg, Nisha Limaye, Véronique Préat A, Alessio Malfanti · 2024 · Materials Today Bio
  78. Stimulating STING for cancer therapy: Taking the extracellular route
    Lingyin Li · 2024 · Cell chemical biology
  79. Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
    Bart Spiesschaert, Katharina Angerer, John Park, Guido Wollmann · 2021 · Cancers
  80. A trinity STING-activating nanoparticle harnesses cancer cell STING machinery for enhanced immunotherapy
    Yanming Xia, Bo Shi, Keke Wang, Li‐Xin Hu, Qiran Wang, Shuxian Xu, Xiaohu Wang, Pengcheng Xu, Yuanbin She, Haitang Xie et al. · 2024 · Journal of Controlled Release
  81. Enhancing nano-immunotherapy of cancer through cGAS–STING pathway modulation
    Gaohong Fu, Yanan Zhao, Chengqiong Mao, Yang Liu · 2025 · Biomaterials Science
  82. Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy
    Zhaomeng Wang, Yongjun Wang, Zhonggui He, Caigang Liu · 2025 · Advanced Science
  83. STINGing Cancer: Development, Clinical Application, and Targeted Delivery of STING Agonists
    Yannick Gabriel Nerdinger, Amanda Katharina Binder, Franziska Bremm, Niklas Feuchter, Niels Schaft, Jan Dörrie · 2025 · International Journal of Molecular Sciences
  84. The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway
    Juan Lv, Chunlei Xing, Yuhong Chen, Huihui Bian, Nanning Lv, Zhibin Wang, Mingming Liu, Li Su · 2022 · Pharmaceuticals
  85. The Many Ways to Deal with STING
    Claire Coderch, Javier Arranz-Herrero, Estanislao Nistal‐Villán, Beatriz de Pascual‐Teresa, Sergio Rius‐Rocabert · 2023 · International Journal of Molecular Sciences
  86. Novel emerging nano-assisted anti-cancer strategies based on the STING pathway
    Xianghui Li, Haoran Wang, Yuanyuan Chen, Zhiyan Li, Song Liu, Wenxian Guan, Youkun Lin, Cunwei Cao, Wenjun Zheng, Jinhui Wu · 2023 · Acta Materia Medica
  87. Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants
    Chengjie Huang, Xiao Zhi, Tianbao Ye, Xiuyuan Wang, Ke Li, Yiyang Li, Qiang Zhang, Lai Jiang, Xianting Ding · 2024 · Journal of Controlled Release
  88. Bifunctional black phosphorus quantum dots platform: Delivery and remarkable immunotherapy enhancement of STING agonist
    Yujun Zhang, Shijing Wang, Hyeonji Rha, Chang Xu, Yue Pei, Xiaoyuan Ji, Junmin Zhang, Ruitao Lu, Shaochong Zhang, Zhongjian Xie et al. · 2024 · Biomaterials
  89. Decomposable STING nanoagonist-amplified oncolytic virotherapy through remodeling the immunosuppressive microenvironment of triple-negative breast cancer
    Min Mu, Guoqing Wang, Bo Chen, Hui Li, Chenqian Feng, Rangrang Fan, Nianyong Chen, Bo Ram Han, Aiping Tong, Bingwen Zou et al. · 2025 · Journal of Materials Chemistry B
  90. Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies
    Sumin Yang, Jieun Seo, Jeonghyeon Choi, Sung-Hyun Kim, Yunmin Kuk, Kyung Chan Park, Mingon Kang, Sangwon Byun, Jae‐Yeol Joo · 2025 · Molecular Cancer
  91. Coordinated modulation of glucose metabolism and immunity via metal-drug nanovesicles for hepatocellular carcinoma therapy
    Mengjie Kong, Liyan Qiu · 2025 · Journal of Controlled Release
  92. Tumor Microenvironment Profiles Reveal Distinct Therapy-Oriented Proteogenomic Characteristics in Colorectal Cancer
    Nan Wang, Rongshui Wang, Xia Li, Zhentao Song, Lingbo Xia, Jue Wang, Li Zhang, Aiwen Wu, Zhiyong Ding · 2021 · Frontiers in Bioengineering and Biotechnology
  93. cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma
    Shashwat Tripathi, Hinda Najem, Akanksha Mahajan, Peng Zhang, Justin Low, Alexander H. Stegh, Michael A. Curran, David M. Ashley, Charles David James, Amy B. Heimberger · 2022 · F1000Research
  94. Arabinose- and xylose-modified analogs of 2′,3′-cGAMP act as STING agonists
    Wei Xie, Lodoe Lama, Xuejing Yang, Vitaly Kuryavyi, Shibani Bhattacharya, Ilona Nudelman, Guangli Yang, Ouathek Ouerfelli, Joseph Fraser Glickman, Roger A. Jones et al. · 2023 · Cell chemical biology
  95. Antitumor Effect of Platinum-Modified STING Agonist MSA-2
    Mo Wang, Ya Cai, He Tian, Yuhang Zhang, Lirong Yi, Wenqing Li, Peng Zhou · 2024 · ACS Omega
  96. Activated STING-containing R-EVs from iPSC-derived MSCs promote antitumor immunity
    Linxia Qian, Zhonghan Zhang, Ruhua Zhang, Xueping Zheng, Bei-Bei Xiao, Xiaomin Zhang, Yuanzhong Wu, Yang Chen, Xingding Zhang, Penghui Zhou et al. · 2024 · Cancer Letters
  97. Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockade
    Hitomi Nishinakamura, Sayoko Shinya, Takuma Irie, Shugo Sakihama, Takeo Naito, Keisuke Watanabe, Daisuke Sugiyama, Motohiro Tamiya, Tatsuya Yoshida, Tetsunari Hase et al. · 2025 · Science Translational Medicine
  98. A chemical agonist and the Golgi-resident lipid PI4P activate STING by inducing transmembrane helix rearrangement
    Jing Han, Shuhao Zhang, Yanfei Hou, Yi Wang, Zhengyin Zhang, Jiaming Yang, Yifang Xu, Zexu Peng, Hang Yin, Kehong Chen et al. · 2025 · Immunity
  99. AND logic nanoparticle for precision immunotherapy of metastatic cancers
    Shuyue Ye, Shuang Chen, Vijay S. Basava, Katy Torres, Yangyang Zhao, Gang Huang, Mingyi Chen, Jinming Gao · 2026 · Nature Nanotechnology
  100. Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19)
    Reza Elahi, Salar Hozhabri Safa, Amirhosein Moradi, Amir Siahmansouri, Armin Jahani Maleki, Abdolreza Esmaeilzadeh · 2023 · Immunopharmacology and Immunotoxicology